SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
62 hedge funds and large institutions have $446M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 68 → 62 (-6)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
62
Holding in Top 10
3
Calls
$1.56M
Puts
$13K
Top Buyers
| 1 | +$40M | |
| 2 | +$31.6M | |
| 3 | +$17.1M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$2.79M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.15M |
Top Sellers
| 1 | -$2.94M | |
| 2 | -$2.76M | |
| 3 | -$2.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$678K |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$374K |